Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87). (2020)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.diabres.2020.108333
PubMed Identifier: 32702468
Publication URI: http://europepmc.org/abstract/MED/32702468
Type: Journal Article/Review
Volume: 166
Parent Publication: Diabetes research and clinical practice
ISSN: 0168-8227